标题
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 10, Issue 7, Pages 377-389
出版商
Springer Nature
发表日期
2013-05-28
DOI
10.1038/nrclinonc.2013.80
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Detection of phosphoinositide-3-kinase, catalytic, and alpha polypeptide (PIK3CA) mutations in matched tissue and plasma samples from patients with metastatic breast cancer.
- (2017) P. Angenendt et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract PD05-08: Genomic characterisation of invasive breast cancers with heterogeneous HER2 gene amplification
- (2014) CKY Ng et al. CANCER RESEARCH
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Implications of Clonal Genome Evolution for Cancer Medicine
- (2013) Samuel Aparicio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer
- (2012) S. T. Ligthart et al. ANNALS OF ONCOLOGY
- Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
- (2012) V. Georgoulias et al. ANNALS OF ONCOLOGY
- ESMO Fellowship Program
- (2012) ANNALS OF ONCOLOGY
- The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
- (2012) Markus Wallwiener et al. BREAST CANCER RESEARCH AND TREATMENT
- Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
- (2012) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
- (2012) Adrian Britschgi et al. CANCER CELL
- P4-07-16: Development of Circulating Tumor Cell-Endocrine Therapy Index in Metastatic Breast Cancer Patients.
- (2012) C Paoletti et al. CANCER RESEARCH
- Abstract 5179: Inhibition of U937-cell adhesion to human endothelial cells by glycosylated lysozyme mutants
- (2012) Ralph Melcher et al. CANCER RESEARCH
- Biologic Challenges in the Detection of Circulating Tumor Cells
- (2012) S. A. Joosse et al. CANCER RESEARCH
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
- (2012) L. Zhang et al. CLINICAL CANCER RESEARCH
- Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
- (2012) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
- (2012) M. J. Higgins et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Considerations in the development of circulating tumor cell technology for clinical use
- (2012) David R Parkinson et al. Journal of Translational Medicine
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
- (2012) Clara Montagut et al. NATURE MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in First-Line Treatment for Patients with HER-2+ Metastatic Breast Cancer
- (2012) L. De Mattos-Arruda et al. ONCOLOGIST
- Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
- (2012) Ashley A. Powell et al. PLoS One
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients
- (2011) F. Reyal et al. ANNALS OF ONCOLOGY
- High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
- (2011) J.- Y. Pierga et al. ANNALS OF ONCOLOGY
- Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
- (2011) Brigitte Rack et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast
- (2011) Malgorzata Banys et al. BREAST CANCER RESEARCH AND TREATMENT
- The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
- (2011) Malgorzata Banys et al. BREAST CANCER RESEARCH AND TREATMENT
- Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
- (2011) George Somlo et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of HER2 amplification in circulating free DNA in patients with breast cancer
- (2011) K Page et al. BRITISH JOURNAL OF CANCER
- Abstract 6: A triple-helix forming oligonucleotide targeting a genomic locus is capable of sequence specific mutagenesis in human lymphoblastoid TK6 cells
- (2011) Reshat Reshat et al. CANCER RESEARCH
- Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials
- (2011) Lot A. Devriese et al. CANCER TREATMENT REVIEWS
- mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
- (2011) A. M. Sieuwerts et al. CLINICAL CANCER RESEARCH
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
- (2011) J. A. Shaw et al. GENOME RESEARCH
- Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
- (2011) Bahriye Aktas et al. GYNECOLOGIC ONCOLOGY
- Circulating tumor cells: approaches to isolation and characterization
- (2011) Min Yu et al. JOURNAL OF CELL BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
- (2011) Todd W. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls
- (2011) Brian Leyland-Jones et al. LANCET ONCOLOGY
- PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. MOLECULAR CANCER THERAPEUTICS
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- Challenges translating breast cancer gene signatures into the clinic
- (2011) Britta Weigelt et al. Nature Reviews Clinical Oncology
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
- (2011) B Weigelt et al. ONCOGENE
- HER2-Positive Circulating Tumor Cells in Breast Cancer
- (2011) Michail Ignatiadis et al. PLoS One
- Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
- (2010) N. Berrada et al. ANNALS OF ONCOLOGY
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Cells and Biomarkers: Implications for Personalized Targeted Treatments for Metastatic Breast Cancer
- (2010) James M. Reuben et al. Breast Journal
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- (2010) L M Flores et al. BRITISH JOURNAL OF CANCER
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- CA 15-3: Uses and limitation as a biomarker for breast cancer
- (2010) Michael J. Duffy et al. CLINICA CHIMICA ACTA
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
- (2010) David J. McBride et al. GENES CHROMOSOMES & CANCER
- Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
- (2010) Gayatri Sharma et al. LIFE SCIENCES
- Next Generation Sequencing of Serum Circulating Nucleic Acids from Patients with Invasive Ductal Breast Cancer Reveals Differences to Healthy and Nonmalignant Controls
- (2010) J. Beck et al. MOLECULAR CANCER RESEARCH
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Molecular mechanisms of metastasis in breast cancer—clinical applications
- (2010) Michal Mego et al. Nature Reviews Clinical Oncology
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
- (2009) F.-C. Bidard et al. ANNALS OF ONCOLOGY
- Effect of Adjuvant Chemotherapy on Integrity of Free Serum DNA in Patients with Breast Cancer
- (2009) Ugur Deligezer et al. Annals of the New York Academy of Sciences
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
- (2009) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- Inferring tumor progression from genomic heterogeneity
- (2009) N. Navin et al. GENOME RESEARCH
- Utility of Serum HER2 Extracellular Domain Assessment in Clinical Decision Making: Pooled Analysis of Four Trials of Trastuzumab in Metastatic Breast Cancer
- (2009) Siân Lennon et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
- (2009) Nikolaos Xenidis et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
- (2009) Felipe C Geyer et al. JOURNAL OF PATHOLOGY
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
- (2009) Seigo Nakamura et al. Breast Cancer
- HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
- (2008) Julie E. Lang et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
- (2008) Mitra Tewes et al. BREAST CANCER RESEARCH AND TREATMENT
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
- (2008) V. Serra et al. CANCER RESEARCH
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
- (2008) J.-Y. Pierga et al. CLINICAL CANCER RESEARCH
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started